Annual

BENIGN HEMATOLOGY
League Summit

Within GCC Hematology Hub

Uniting hematology experts to advance benign hematology care, foster collaboration, and drive better outcomes across the GCC and beyond.

24 October 2026
DoubleTree by Hilton, Fujairah, UAE
Red blood cells and molecular network over the Fujairah skyline
Annual

BENIGN HEMATOLOGY
League Summit

Within GCC Hematology Hub

Uniting hematology experts to advance benign hematology care, foster collaboration, and drive better outcomes across the GCC and beyond.

24 October 2026
DoubleTree by Hilton, Fujairah, UAE
300+
Attendees
15+
Expert Speakers
4+
Scientific Sessions
20+
Talks
“

It is with great pleasure that I welcome you to the 2nd Annual Benign Hematology League Summit, held on the 24th of October 2026 in Fujairah. This event brings together experts, researchers, healthcare professionals, and advocates from around the region, united by a shared commitment to advancing the science and practice in the field of Benign Hematology.

Our aim is not only to save lives, but to restore function and improve quality of life for our patients.

Dr. Wayne Kleintjes
Dr. Mozah AlMarshoodiSummit Chairperson
Acting Head of Medical Department
Sheikh Khalifa Hospital, Fujairah
Welcome message

Transforming and Advancing Benign Hematology

Throughout the summit, we will engage in detailed discussions, exchange invaluable insights, and share research outcomes that will shape the future of clinical practices in the field of benign hematology. Together, we can address key issues.

We hope to inspire collaboration, new ideas, and strengthen the global network of professionals dedicated to enhancing patient care. I look forward to the fruitful discussions and collaborations that will unfold during the course of this summit.

About the Summit

A premier educational event

The Annual Benign Hematology League Summit brings together leading clinicians, researchers, and healthcare professionals to exchange evidence, share expertise, and translate science into better outcomes for patients with benign hematologic disorders.

01

Collaborative Learning

Connect, share, and learn with peers and experts from across the GCC.

02

Evidence to Practice

Actionable insights rooted in the latest research and clinical guidelines.

03

Multidisciplinary Approach

Integrated care across specialties, systems, and care settings.

04

Improved Patient Outcomes

Turning knowledge into meaningful improvements in everyday care.

Speakers

Faculty

Dr. Amar Lal
Dr. Amar Lal
Consultant Hematologist/Oncologist
Tawam Hospital
United Arab Emirates
Bio
Dr. Amar Lal graduated from Dow University in 1993, completing his residency in internal medicine and a fellowship in oncology. He holds triple diplomas in Medicine, Family Medicine, and Oncology from CPSP, along with additional diplomas from the Royal Colleges of Physicians (Ireland and Glasgow), and a Specialty Certificate in Oncology from the Royal College of Physicians, London. He is also certified by the ESMO Examination Board. With over 50 publications, Dr. Lal is an experienced national and international speaker in hematology and oncology. Since 2007, he has been serving at Tawam Hospital, contributing to medical education and patient safety through various leadership and committee roles.
Dr. Amna Al Mehairi
Dr. Amna Al Mehairi
Consultant Hematologist
Dubai Health
United Arab Emirates
Bio
Dr. Amna Al Mehairi is a Consultant Hematologist at Dubai Hospital, Dubai Health, with extensive experience in clinical hematology and the management of hematological malignancies. She also serves as an Adjunct Clinical Professor of Medicine and is core faculty for the Hematology Fellowship Program, contributing actively to postgraduate medical education and training. Her clinical and academic interests include blood cancers, multiple myeloma, leukemia, myeloproliferative disorders and other complex hematological conditions. Dr. Al Mehairi is actively involved in regional research and scientific education and has contributed to publications and expert consensus initiatives in multiple myeloma and thrombotic thrombocytopenic purpura. She is also a certified Epic Physician Builder, supporting digital transformation and innovation in healthcare.
Dr. Anoud AlKindi
Dr. Anoud AlKindi
Acting Head Pediatric Institute
Consultant Pediatrician, Sheikh Khalifa Hospital Fujairah
United Arab Emirates
Bio
Dr. Anoud Khalfan AlKindi is a Pediatric Consultant with 12 years of experience in general pediatrics. Her clinical interests include infant and child development, routine well-baby care, management of acute and chronic pediatric conditions, disease prevention, and community health awareness. She holds a Bachelor of Medicine and Surgery (MBBS) from the United Arab Emirates University and completed her Pediatric Residency Program at Tawam Hospital. She is Arab Board Certified in Pediatrics and also holds a Master of Science in Public Health from Hamdan Bin Mohammed Smart University. Dr. AlKindi is committed to providing comprehensive, patient-centered pediatric care while promoting preventive health and community awareness.
Dr. Asma Alblooshi
Dr. Asma Alblooshi
EOHNS President
Adult Hematology Nurse, Tawam Hospital
United Arab Emirates
Bio
Asma is the Acting Nurse Manager at Tawam Hospital, with a wide range of expertise in the hematology, oncology and palliative, also had position of Hematology/oncology navigator which has supported her experience with patients. She is the winner of Daisy Award and SEHA IHSAN Award, ENA member and trainee in RCSI SEHA program. Moderator in International Medical Conferences, Instructor in Oncology Educational Program and member of Oncology Nursing Advisory Group at SEHA.
Dr. Asma Sultan Al Olama
Dr. Asma Sultan Al Olama
President, Emirates Society of Haematology
Consultant Hematologist, Dubai Hospital
United Arab Emirates
Bio
Dr. Asma Al Olama is the President of the Emirates Society of Haematology and a Consultant Hematologist at Dubai Hospital. She has been actively involved in the field of hematology, particularly in the UAE, and has contributed to various initiatives and best practices in the area. Additionally, she serves as the Program Director of the Adult Hematology Fellowship program at Dubai Health.
Dr. Deepthi Boddu
Dr. Deepthi Boddu
United Arab Emirates
Bio
Dr. Fatema Alwusibai
Dr. Fatema Alwusibai
Hematology Consultant
Al Rass General Hospital, Al-Qassim
Saudi Arabia
Bio
Dr. Fatemah AlWusibai is a consultant hematologist at King Fahad Specialist Hospital, Saudi Arabia, with a focused practice in classical and benign hematology. Her clinical expertise includes immune thrombocytopenia, autoimmune hemolytic anemia, and platelet disorders, with a strong interest in evidence-based decision-making and real-world outcomes. She is actively involved in academic activities and systematic reviews addressing clinically relevant questions in hematology practice. Dr. AlWusibai regularly participates in regional scientific meeting and values collaborative work across multidisciplinary and international hematology teams, with a particular interest in advancing patient-centered care within the Gulf region.
Dr. Hadeel Ammar
Dr. Hadeel Ammar
Consultant Hematologist
Dubai Hospital
United Arab Emirates
Bio
Dr. Hadeel Mahmmoud Ammar is a Consultant in Internal Medicine, Hematology, and Pathology at Dubai Hospital, Dubai Health Authority (DHA). With over 23 years of clinical experience, she specializes in managing complex hematologic and systemic disorders. Dr. Ammar earned her MBBS from Dubai Medical College and completed her Arab Board certification with training in Syria. She is known for her patient-centered, evidence-based approach and plays an active role in clinical education and multidisciplinary care initiatives across the UAE.
Dr. Hani Osman
Dr. Hani Osman
Consultant Adult Clinical Haematology
Tawam Hospital
United Arab Emirates
Bio
Dr. Hani Yousif Osman is a UK-trained consultant physician in medicine, hematology, and oncology at Tawam Hospital. He specializes in the diagnosis and treatment of hematologic malignancies, including leukemia, lymphoma, and multiple myeloma, as well as benign blood and bleeding disorders. A graduate of University of Khartoum, he completed advanced training in the United Kingdom and has published research in his field.
Dr. Hassan Khammas Alyammahi
Dr. Hassan Khammas Alyammahi
Consultant Nephrologist
Sheikh Khalifa Hospital Fujairah
United Arab Emirates
Bio
Dr. Hassan Khammas Alyammahi is a Consultant Nephrologist at Sheikh Khalifa Hospital, Fujairah, with extensive clinical, academic, and healthcare leadership experience. He previously served as Acting CMO, Head of Nephrology, Head of Medical Department, and Medical Director in Fujairah. He holds an MMEDSci in Nephrology from Sheffield University and an MD in Nephrology from Cardiff University, alongside training in kidney and pancreas transplantation. His professional interests include chronic kidney disease, hypertension, cardiorenal syndrome, dialysis, transplantation, and point-of-care kidney ultrasound. He is a member of the American Society of Nephrology and contributes to research, guideline development, medical education, and leadership initiatives.
Dr. Hiba Khogali
Dr. Hiba Khogali
United Arab Emirates
Bio
Dr. Husni Al Hateeti
Dr. Husni Al Hateeti
Consultant Hematologist/Oncologist
Sheikh Shakhbout Medical City
United Arab Emirates
Bio
Dr. Hateeti has extended experience in Haematology, Oncology, and Internal Medicine, having worked for more than 25 years in the field. He was a lead physician in Haematology at Shiekh Khalifa Medical City (SKMC) for more than a decade and currently, he is a lead physician in lymphoma and benign Haematology at Sheikh Shakhbout Medical City. In addition, Dr. Hateeti was a principal investigator and co-investigator in international multi-centre medical trials and has papers published in regional medical journals. He has a special interest in lymphoma and rare haematology disorders; HLH, PNH, TTP/HUS, haematologic storage disorders like Gaucher disease, beta-thalassemia, and other hemoglobinopathies.
Dr. Joanna Fraser
Dr. Joanna Fraser
Specialist Obstetrician & Gynaecologist
Mediclinic Dubai Mall
United Arab Emirates
Bio
Dr Joanna Fraser is a Consultant Obstetrician and Gynaecologist with specialist expertise in the management of women and girls with inherited bleeding disorders. She holds an MD (Research) from University College London, with a research focus on inherited bleeding disorders, pregnancy, haemostasis and reproductive health. Her clinical and academic work spans the challenges of bleeding disorders across the reproductive lifespan, including menstruation, fertility, pregnancy and childbirth. Dr Fraser has presented internationally and is an invited speaker and panellist for the World Federation of Hemophilia and Haemophilia Society. She is passionate about improving recognition, diagnosis and awareness of bleeding disorders in women and promoting effective multidisciplinary care.
Dr. Mahmoud Marashi
Dr. Mahmoud Marashi
Vice President, Emirates Society of Haematology
Consultant Hematologist, Mediclinic City Hospital
United Arab Emirates
Bio
Prof. Mahmoud Marashi is a Consultant Haematologist at Mediclinic City Hospital with over 30 years of experience. He established the clinical haematology service in Dubai Health Authority, managing both benign (anemias, bleeding disorders, thrombosis) and malignant (leukemias, myeloma, myeloproliferative disorders) hematologic conditions. A Professor of Medicine and Haematology, he leads undergraduate and postgraduate haematology training at Dubai Medical College, serves as Head of the Academic Department of Medicine, and is an external examiner for the Royal College of Physicians, UK.
Dr. Manuel Algora
Dr. Manuel Algora
Consultant in Transfusion Medicine, Department of Pathology and Laboratory Medicine
Sheikh Shakhbout Medical City
United Arab Emirates
Bio
A distinguished medical professional with over 30 years of experience in transfusion medicine, Dr. Algora brings extensive expertise in diagnosing and treating various blood-related disorders. Skilled in the rational use of blood and its components in surgical and medical settings, he excels in organising and leading transfusion services. Additionally, he is highly skilled in apheresis procedures, autologous programmes, and patient blood management programmes, offering alternatives to blood transfusion. As a visionary, Dr. Algora is well-versed in integrating innovation and technology for the efficient administration of blood, interfacing with different IT systems seamlessly. He is experienced in implementing medical policies and standards to ensure patient care, vigilance, and safety during interventions, consistently achieving clinical excellence.
Dr. Maryam Darwish
Dr. Maryam Darwish
Consultant Clinical Hematology
Sheikh Khalifa Specialty Hospital
United Arab Emirates
Bio
Dr. Maryam Darwish, MD, FRCPC, is a Canadian Board-certified Consultant Clinical Hematologist, Internist, and Professor, specializing in hemoglobinopathies and benign hematological disorders. She earned her MSc in Leadership in Health Professions Education from the University of Sharjah (2025). Trained at McMaster University and Toronto General Hospital, she founded the Hemoglobinopathy Clinic at Sheikh Khalifa Specialty Hospital. Dr. Darwish serves as Adjunct Clinical Professor at RAK Medical and Health Sciences University and teaches at Ajman University. As Internship Program Coordinator at MOPA hospitals, she mentors future doctors. Her work reflects dedication to clinical care, and medical education in the UAE.
Dr. Mohamed Abuhaleeqa
Dr. Mohamed Abuhaleeqa
Consultant, Hematology & Bone Marrow Transplant / Chair of Academic Affairs
Abu Dhabi Stem Cells Center
United Arab Emirates
Bio
Dr. Mohamed Abuhaleeqa is an esteemed Consultant in Hematology, Leukemia, and Bone Marrow Transplant. With a robust medical journey that includes qualifications from prestigious institutions and a specialization in Hematology, he is a dedicated healthcare leader. Dr. Abuhaleeqa's commitment to knowledge sharing is evident through his mentoring of junior doctors and his role as the Program Director for the Hematology Fellowship Program in the UAE. His extensive qualifications include FRCPSC in Leukemia and Bone Marrow Transplant, Hematology, and Internal Medicine, and he is registered with the College of Physicians and Surgeons of British Columbia. He is an active participant in seminars, symposiums, and research in hematology and a member of respected medical associations, including ASBMT, EBMT and CIBMTR, underscoring his dedication to healthcare advancement in the UAE.
Dr. Nameer Al Saadawi
Dr. Nameer Al Saadawi
Senior Consultant Clinical Hematology
Yas Clinic - Khalifa City
United Arab Emirates
Bio
Dr. Nameer Al-Saadawi is a Senior Consultant in Clinical Hematology at Yas Clinic Khalifa City and serves as Consultant Hematologist, Deputy Chief Medical Officer and Chair of Medicine at Abu Dhabi Stem Cells Center. With more than 25 years of experience across the UAE and Sweden, he completed his medical degree at the University of Baghdad before undertaking specialist training in Internal Medicine and Clinical Hematology in Sweden. His clinical expertise includes leukemia, lymphoma, multiple myeloma, myeloproliferative disorders and hematopoietic stem-cell transplantation. Dr. Al-Saadawi also leads the Abu Dhabi Bone Marrow Transplant Program and has contributed to the advancement of hematology and cellular therapy services in the UAE.
Dr. Ramadan Arafa
Dr. Ramadan Arafa
Consultant Physician and Nephrologist
Fujairah Hospital
United Arab Emirates
Bio
Dr. Ramadan Arafa is a Consultant Physician and Nephrologist at Fujairah Hospital. He graduated from Mansoura University in 1990 and earned his Master’s degree in Internal Medicine in 1997. Dr. Arafa holds MRCPI (2010) and FRCPI (2016) qualifications and was awarded his MD in Internal Medicine in 2017. He has extensive experience in internal medicine and nephrology practice.
Dr. Reima Obaid AlMarshoodi
Dr. Reima Obaid AlMarshoodi
Specialist
Sheikh Khalifa Hospital Fujairah
United Arab Emirates
Bio
Dr. Reima AlMarshoodi is a consultant nephrologist and internal medicine based in the United Arab Emirates, with expertise spanning nephrology, internal medicine, and organ transplantation. She holds Arab Board certifications in Nephrology and Internal Medicine, and Master’s degrees in Organ Transplantation and Leadership and Innovation in Healthcare. Her clinical interests include complex kidney disease, acute kidney injury, transplantation, and renal manifestations of systemic disorders. Alongside her clinical practice, she is actively engaged in healthcare quality, patient safety, education, and clinical research, with several nephrology publications and presentations at national and international scientific conferences.
Dr. Sally Al-Naeem
Dr. Sally Al-Naeem
Pediatrics - Consultant Pediatric Hematology/Oncology
Saqr Hospital
United Arab Emirates
Bio
Dr. Sally Al Naeem is a Consultant in Pediatric Hematology and Oncology. She earned her medical degree and completed her pediatric residency in the United Arab Emirates, followed by an international fellowship in Pediatric Hematology and Oncology in Ireland. She has held key leadership roles, including serving as Medical Director of Saqr Hospital in the UAE, where she contributed to advancing pediatric services and multidisciplinary care. Her clinical expertise spans the diagnosis and management of pediatric blood disorders, with particular focus on hemophilia and other inherited bleeding disorders. Dr. Al Naeem has made notable regional and international contributions to pediatric hematology and oncology through her academic work and active participation in scientific forums. She is deeply involved in medical education, serves as a peer reviewer for medical journals, and regularly delivers lectures at national and international conferences, reflecting her commitment to advancing the field and sharing expertise across the region and beyond.
Dr. Shahad Alzaabi
Dr. Shahad Alzaabi
Consultant Obstetrician & Gynecologist, Acting Head of Women’s Health Institute
Sheikh Khalifa Hospital Fujairah
United Arab Emirates
Bio
Dr. Shahad Saeed Alzaabi is a Consultant Obstetrician and Gynecologist at Sheikh Khalifa Hospital, Fujairah, where she is also identified in the conference materials as Acting Head of the Women’s Health Institute. Her clinical interests include general obstetrics, general gynecology, fetal-maternal medicine, cosmetic gynecology, and high-risk pregnancy. She holds an Arab Board in Obstetrics and Gynecology and has 20 years of experience. She is part of the Women’s Health Institute at Sheikh Khalifa Hospital, Fujairah, which provides obstetric and gynecological services and includes her among its available consultants. Dr. Alzaabi has also been involved in the EHS International Obstetrics & Gynecology Conference series. At the 4th EHS International Obstetrics & Gynecology Conference in 2025, she served as a Chairperson, alongside Dr. Hosam Elhalwagy, for a scientific session. For the 5th EHS International Obstetrics & Gynecology Conference, she is listed as a Lead Faculty member and Scientific Committee member. The official conference listing identifies her as “Consultant OBGYN, Acting HOD Women institute.”
Dr. Somaya Alnuaimi
Dr. Somaya Alnuaimi
Pediatric Hematologist
Fujairah Hospital
United Arab Emirates
Bio
Dr. Somaya Al Nuaimi is a Pediatric Consultant and Head of the Thalassemia Department at Fujairah Hospital, with over 20 years of clinical experience. She led the department to recognition as a Center of Excellence and is an Associate Professor at Ras Al Khaimah Medical University. Holding MRCPCH and Arab Board certification, she is an active educator, speaker, and certified trainer, contributing extensively to pediatric care and professional development in the UAE.
Dr. Suliman Al Shamsi
Dr. Suliman Al Shamsi
Consultant Vascular & Endovascular Surgeon | Chief of Vascular Surgery
President, Emirates Vascular Surgery Society | Program Director, General Surgery Residency Program
United Arab Emirates
Bio
Senior vascular and endovascular surgeon with more than 25 years of surgical experience, including advanced open and endovascular arterial, venous, vascular access and complex aortic surgery. Extensive clinical leadership, residency education and service-development experience in the UAE and Oman. Currently Chief of Vascular Surgery at Sheikh Tahnoon Bin Mohammed Medical City (STMC), President of the Emirates Vascular Surgery Society (EVSS), and Program Director of the General Surgery Residency Program.
Prof. Mohamed Yassin
Prof. Mohamed Yassin
Senior Consultant Hematologist
Chairman - Hematology Academy
Qatar
Bio
Prof. Prof. Mohamed A. Yassin is a Senior Consultant Hematologist at the National Center for Cancer Care and Research, and Professor of Hematology at Qatar University. His key interests include myeloproliferative neoplasms, thalassemia, and sickle cell disease. He has led numerous international collaborations and clinical trials, focusing on cancer biomarkers and therapeutics, with research partnerships in France and Italy. Prof. Yassin remains deeply committed to advancing hematologic research in Qatar and beyond.
24 October 2026

Program Higlights

At the Crossroads of Hematology and Nephrology: Complement-Mediated and Thrombotic Disorders

Hematologic Disorders in Obstetrics and Women's Health: From Preconception to the Postpartum Period

Pediatric Hematology: From Early Diagnosis to Precision-Guided Therapy

Core Concepts and Contemporary Updates in Benign Hematology

Hemoglobinopathies: Bridging Pathophysiology and Novel Disease-Modifying Therapies

Bleeding Emergencies Across Clinical Settings: A Multidisciplinary Perspective

Leadership and Professional Development in Hematology: A Masterclass for the Modern Practitioner

View Full Program
Registration

Early Bird Rates

Reserve your place at BHS 2026. All rates are in USD, exclusive of 5% VAT.

Physician
$250
Full conference access
Allied Health
$150
Allied health professionals
Nurse
$150
Registered nurses
Resident
$150
Residents in training
Student
$75
Medical students
Your registration includes
Access to:
  • Session Halls
  • Exhibition Halls
  • Workshops
  • Lunch & Coffee Breaks
  • Final Program
  • Mobile App
Register Now
Plan ahead

Important dates

1 Aug
2026
Program topics announced
5 Sep
2026
Speakers & Faculty Announced
25 Sep
2026
Early-bird registration closes
25 Sep
2026
CME Announcement
23 Oct
2026
Standard Registration Close
24 Oct
2026
Annual Benign Hematology League Summit Goes Live
Where

The venue

DoubleTree by Hilton Fujairah City is a modern 4-star hotel offering a comfortable and welcoming stay in the picturesque city of Fujairah. With its spacious rooms, relaxing outdoor pool, and a variety of dining options, the hotel caters to both leisure and business travelers. Enjoy the warm hospitality of DoubleTree by Hilton, coupled with the stunning natural beauty of Fujairah.

View venue details
DoubleTree by Hilton
Fujairah, United Arab Emirates
Supported by

Sponsors & partners

The Annual Benign Hematology League Summit 2026 provides a premier stage for healthcare leaders, educators, and innovators focused on hematologic diseases to share insights, exchange knowledge, and highlight groundbreaking products and services.But the journey doesn’t stop there.

The conference also serves as a launchpad for your brand, enabling you to amplify visibility, strengthen credibility, and foster trust with your audience. By engaging in this global platform, you position your brand for long-term growth and success.
Sponsorship enquiry

Be part of the future of benign hematology care

Join us in shaping better outcomes through collaboration, education, and innovation.

Register Now
View ProgramRegister Now